Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05349084 · ClinicalTrials.gov registry record · NA

PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR

A NA study of Coronary Artery Disease, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT05349084: Completed NA study of Coronary Artery Disease, sponsored by Washington University School of Medicine.

NCT05349084 is a NA study of Coronary Artery Disease that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05349084, a NA study of Coronary Artery Disease, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The broad, long-term objective of this pilot study is to develop an optimal, clinically usable, non-invasive evaluation of Coronary Artery Disease (CAD) in the setting of stable angina which provides both anatomic and functional information. Patients already scheduled to undergo Invasive coronary catheterization (ICA) for the clinical indication of angina will be recruited to under go stress-rest Positron Emission Tomography-Coronary CT Angiography-Fractional Flow Reserve (PET-cCTA-cFFR)

Primary Outcome

CT presence of flow limiting stenosis (≤ 0.8) as determined by CT-FFR in comparison to invasive coronary artery (ICA) FFR. CT-FFR was determined in the following myocardial segments: left anterior descending (LAD), left circumflex (LCx), and right coronary artery (RCA). The number of coronary artery stenoses as determined by CT (CT-FFR ≤ 0.8) was measured.

Conditions Studied

Coronary Artery Disease

Interventions

  • DIAGNOSTIC_TEST PET-cCTA-cFFR

Study Locations (1)

Missouri

  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-06-06
Est. Completion 2023-07-18
Phase NA
Washington University School of Medicine

1,502 total trials

What the finished NCT05349084 record still lists

NCT05349084 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which PET-cCTA-cFFR is the first listed.

NCT05349084 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05349084 about?

NCT05349084 is a clinical study titled "PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR". The broad, long-term objective of this pilot study is to develop an optimal, clinically usable, non-invasive evaluation of Coronary Artery Disease (CAD) in the setting of stable angina which provides both anatomic and functional information. Patients already scheduled to undergo Invasive coronary c...

What is the current status of trial NCT05349084?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-06-06. Estimated completion is 2023-07-18.

What conditions does trial NCT05349084 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT05349084?

The interventions under investigation include: PET-cCTA-cFFR (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05349084?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05349084 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05349084's enrollment target sits among peer trials

21 207th of 219 higher than 12 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05349084, the US trial registry maintained by the National Library of Medicine. NCT05349084 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.